News

Avonex Pen (Avonex 30mcg/0.5mL solution for injection) is the first single-use, once-a-week, fully integrated intramuscular (IM)autoinjector, designed to be easier to use than currently available Avonex prefilled syringe.

The University of California San Francisco has received Investigational Review Board (IRB) approval. The single-arm, open-label and multi-center study will enroll up to 25 patients with stage III

ET-101 is a novel therapeutic antibody, currently under investigation for the inhibition of the growth of cancer stem cells. Under the deal, Lonza will produce phase 1 clinical

The company is expected to initiate a Phase I trial with mibefradil in normal healthy volunteers on 2 March 2012. The company will also initiate Phase Ib trial

In January 2011, Dompé has acquired 49% stake in Anabasis and also patent rights for the use of NGF to treat neurotrophic keratitis (NK). Dompé will become the

KDIL is a contract manufacturer of sterile injectables in India, as well as certain assets of NBZ Pharma. Akorn is a pharmaceutical company engaged in the development, manufacture

NanoSonic’s Trappsol Cyclo is FDA and EMEA designated orphan drug for the treatment of Niemann Pick Type-C disease, also known as Childhood Alzheimer’s. Trappsol Cyclo is currently being

Acetadote (acetylcysteine) is injectable drug used to treat acetaminophen overdose, and Caldolor (ibuprofen) Injection is used to treat pain and fever in the hospital setting. According to the

As per the new agreement, Impax will implement the Flex platform, which will drive the expansion of Revitas solutions across the enterprise from the generics division to the